Heather Yeckes-Rodin, M.D.
NPI 1740214840 · Hematology & Oncology Physician · Port St. Lucie, FL
Enrolled with Medicare as Practitioner - Medical Oncology · source: CMS PECOS Public Provider Enrollment (2026.04.01)
Provider details
- NPI number
- 1740214840
- Entity type
- Individual
- Primary specialty
- Hematology & Oncology PhysicianAllopathic & Osteopathic Physicians
- Credential
- M.D.
- Sex
- Female
- Sole proprietor
- No
- License
- 219188 (MA)
Specialties & taxonomies
Allopathic & Osteopathic Physicians
Allopathic & Osteopathic Physicians
Profile Score
A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.
- Registry tenure25% of score
19 yrs in NPPES registry
- Profile completeness25% of score
100% of core fields populated
- Practice footprint15% of score
1 documented practice location
- Medicare service volume (vs. specialty peers)25% of score
15,717 Medicare services, 2024 (ranked within specialty)
- Open Payments transparency10% of score
Has Open Payments disclosures (2024)
Medicare volume is ranked against active providers in the same specialty. Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our .
What this provider does (Medicare)
Based on Medicare fee-for-service claims, 2024; not all care is captured.
| Service (HCPCS) | Medicare services | Typical Medicare-allowed (2024) |
|---|---|---|
| Complete Blood Cell Count (red Cells, White Blood Cell, Platelets), Automated Test and Automated Differential White Blood Cell Count85025 | 2,600 | $8 |
| Blood Test, Comprehensive Group of Blood Chemicals80053 | 2,144 | $10 |
| Established Patient Office Or Other Outpatient Visit With Low Level OD Decision Making, If Using Time, 20 Minutes Or More99213 | 1,771 | $93 |
| Insertion of Needle Into Vein for Collection of Blood Sample36415 | 1,653 | $9 |
| Carcinoembryonic Antigen (cea) Protein Level82378 | 723 | $19 |
| Immunologic Analysis for Detection of Tumor Antigen, Quantitative; Ca 15-386300 | 633 |
What this provider prescribes (Medicare Part D)
Top drugs by Medicare Part D claim volume, 2024 · 71 distinct drugs on file.
| Drug | Part D claims (2024) | Beneficiaries |
|---|---|---|
| Anastrozole | 1,057 | 264 |
| Letrozole | 374 | 83 |
| Tamoxifen Citrate | 345 | 91 |
| Oxycodone Hcl | 170 | 67 |
| Aprepitant | 144 | 52 |
| Palbociclibbrand: Ibrance | 137 | 16 |
| Dexamethasone | 132 | 50 |
| Exemestane | 130 | 36 |
Transparency — industry payments
Based on CMS Open Payments, 2024; not all care is captured.
$5,343 across 206 records (Open Payments 2024)
Open Payments discloses payments and transfers of value (meals, travel, consulting, research, royalties) from drug and device makers to providers. This is a transparency signal, not a verdict — such payments are legal and common, and their presence is neither an endorsement nor a criticism. Source: CMS Open Payments, program year 2024.
Practice location
Mailing address
Registry dates
- Enumerated
- 2006-07-11
- Last updated
- 2009-10-09
Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.